Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2017

16.03.2017 | Basic Science

Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema

verfasst von: Teruyo Kida, Hidehiro Oku, Taeko Horie, Masanori Fukumoto, Yoshitaka Okuda, Seita Morishita, Tsunehiko Ikeda

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aquaporin 4 (AQP4), a water channel protein, is known to be expressed in retinal Müller cells. The purpose of this study was to determine the effects of VEGF and AQP4 channels on the volumetric changes in Müller cells.

Methods

Retinas from diabetic rats and a cultured Müller cell line, TR-MUL5, were used in this study. Intravitreal injections of VEGF or PBS were performed on either streptozotocin (STZ)-induced diabetic or normoglycemic rats. Retinal sections were immunostained for anti-glial fibrillary acidic protein (GFAP), anti-AQP4, and anti-VEGF. VEGF protein levels from collected retinas were determined by western blot analysis. Volumetric changes and nitric oxide (NO) levels in cultured Müller cells were determined using flow cytometry (FACS), in the presence or absence of VEGF and TGN-020, a selective AQP4 inhibitor.

Results

In the diabetic rat retina, VEGF immunoreactivity was concentrated in the internal retinal layers, and AQP4 immunoreactivity was higher than controls. The expressions of AQP4 were colocalized with GFAP. Protein levels of VEGF in the hyperglycemic rat retina were significantly higher than controls. FACS analyses showed that exposure to VEGF enlarged Müller cells, while exposure to TGN-020 suppressed the enlargement. Intracellular levels of NO were increased after exposure to VEGF, which was suppressed following the addition of TGN-020.

Conclusion

The observed Müller cell swelling is mediated by VEGF and AQP4.
Literatur
1.
Zurück zum Zitat Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB (2011) Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis 17:300–308PubMedPubMedCentral Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB (2011) Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis 17:300–308PubMedPubMedCentral
3.
Zurück zum Zitat Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jurgens I, Smets RM, Coriat C, Wiedemann P, Agoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Cunha-Vaz J, Evicr.net (2015) Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2. Ophthalmic Res 54:112–117. doi:10.1159/000438792 CrossRefPubMed Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jurgens I, Smets RM, Coriat C, Wiedemann P, Agoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Cunha-Vaz J, Evicr.net (2015) Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2. Ophthalmic Res 54:112–117. doi:10.​1159/​000438792 CrossRefPubMed
8.
Zurück zum Zitat Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL 3rd, Glassman AR, Maturi RK, Stockdale CR, Topping TM (2011) Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology 118:e5–e14. doi:10.1016/j.ophtha.2011.09.058 CrossRefPubMedPubMedCentral Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL 3rd, Glassman AR, Maturi RK, Stockdale CR, Topping TM (2011) Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology 118:e5–e14. doi:10.​1016/​j.​ophtha.​2011.​09.​058 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17:171–180PubMed Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17:171–180PubMed
11.
Zurück zum Zitat Bringmann ARA, Wiedermann P (2004) Pathomechanisms of cystoid macular edema. Ophthalmic Res 36:241–249CrossRefPubMed Bringmann ARA, Wiedermann P (2004) Pathomechanisms of cystoid macular edema. Ophthalmic Res 36:241–249CrossRefPubMed
15.
17.
Zurück zum Zitat Gunnarson E, Zelenina M, Axehult G, Song Y, Bondar A, Krieger P, Brismar H, Zelenin S, Aperia A (2008) Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 56:587–596. doi:10.1002/glia.20627 CrossRefPubMed Gunnarson E, Zelenina M, Axehult G, Song Y, Bondar A, Krieger P, Brismar H, Zelenin S, Aperia A (2008) Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 56:587–596. doi:10.​1002/​glia.​20627 CrossRefPubMed
18.
Zurück zum Zitat Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207–218CrossRefPubMed Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207–218CrossRefPubMed
21.
Zurück zum Zitat Tomi M, Funaki T, Abukawa H, Katayama K, Kondo T, Ohtsuki S, Ueda M, Obinata M, Terasaki T, Hosoya K (2003) Expression and regulation of L-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL). Glia 43:208–217. doi:10.1002/glia.10253 CrossRefPubMed Tomi M, Funaki T, Abukawa H, Katayama K, Kondo T, Ohtsuki S, Ueda M, Obinata M, Terasaki T, Hosoya K (2003) Expression and regulation of L-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL). Glia 43:208–217. doi:10.​1002/​glia.​10253 CrossRefPubMed
23.
Zurück zum Zitat Vogler S, Grosche A, Pannicke T, Wiedemann P, Reichenbach A, Bringmann A (2016) Endothelins inhibit osmotic swelling of rat retinal glial and bipolar cells by activation of growth factor signaling. Neurochem Res. doi:10.1007/s11064-016-1971-4 Vogler S, Grosche A, Pannicke T, Wiedemann P, Reichenbach A, Bringmann A (2016) Endothelins inhibit osmotic swelling of rat retinal glial and bipolar cells by activation of growth factor signaling. Neurochem Res. doi:10.​1007/​s11064-016-1971-4
24.
26.
Zurück zum Zitat Klettner A, Westhues D, Lassen J, Bartsch S, Roider J (2013) Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor kappaB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Mol Vis 19:281–291PubMedPubMedCentral Klettner A, Westhues D, Lassen J, Bartsch S, Roider J (2013) Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor kappaB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Mol Vis 19:281–291PubMedPubMedCentral
28.
Zurück zum Zitat Stone J, Itin A, Alon T, Pe’er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738–4747PubMed Stone J, Itin A, Alon T, Pe’er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738–4747PubMed
29.
Zurück zum Zitat Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed
30.
Zurück zum Zitat Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–1828CrossRefPubMed Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–1828CrossRefPubMed
33.
Zurück zum Zitat Newman E, Reichenbach A (1996) The Muller cell: a functional element of the retina. Trends Neurosci 19:307–312CrossRefPubMed Newman E, Reichenbach A (1996) The Muller cell: a functional element of the retina. Trends Neurosci 19:307–312CrossRefPubMed
34.
Zurück zum Zitat Qin Y, Ren H, Hoffman MR, Fan J, Zhang M, Xu G (2012) Aquaporin changes during diabetic retinopathy in rats are accelerated by systemic hypertension and are linked to the renin-angiotensin system. Invest Ophthalmol Vis Sci 53:3047–3053. doi:10.1167/iovs.11-9154 CrossRefPubMed Qin Y, Ren H, Hoffman MR, Fan J, Zhang M, Xu G (2012) Aquaporin changes during diabetic retinopathy in rats are accelerated by systemic hypertension and are linked to the renin-angiotensin system. Invest Ophthalmol Vis Sci 53:3047–3053. doi:10.​1167/​iovs.​11-9154 CrossRefPubMed
35.
Zurück zum Zitat Oku H, Morishita S, Horie T, Kida T, Mimura M, Fukumoto M, Kojima S, Ikeda T (2015) Nitric oxide increases the expression of aquaporin-4 protein in rat optic nerve astrocytes through the cyclic guanosine monophosphate/protein Kinase G pathway. Ophthalmic Res 54:212–221. doi:10.1159/000440846 CrossRefPubMed Oku H, Morishita S, Horie T, Kida T, Mimura M, Fukumoto M, Kojima S, Ikeda T (2015) Nitric oxide increases the expression of aquaporin-4 protein in rat optic nerve astrocytes through the cyclic guanosine monophosphate/protein Kinase G pathway. Ophthalmic Res 54:212–221. doi:10.​1159/​000440846 CrossRefPubMed
36.
Zurück zum Zitat Kruzliak P, Novak J, Novak M (2014) Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors. Am J Hypertens 27:3–13. doi:10.1093/ajh/hpt201 CrossRefPubMed Kruzliak P, Novak J, Novak M (2014) Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors. Am J Hypertens 27:3–13. doi:10.​1093/​ajh/​hpt201 CrossRefPubMed
37.
Zurück zum Zitat Shen BQ, Lee DY, Zioncheck TF (1999) Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274:33057–33063CrossRefPubMed Shen BQ, Lee DY, Zioncheck TF (1999) Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274:33057–33063CrossRefPubMed
Metadaten
Titel
Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema
verfasst von
Teruyo Kida
Hidehiro Oku
Taeko Horie
Masanori Fukumoto
Yoshitaka Okuda
Seita Morishita
Tsunehiko Ikeda
Publikationsdatum
16.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 6/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3631-z

Weitere Artikel der Ausgabe 6/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.